These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1282958)

  • 1. Endothelium-derived relaxing factor modulates renal interstitial cyclic GMP.
    Siragy HM
    J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S163-5. PubMed ID: 1282958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide alters renal function and guanosine 3',5'-cyclic monophosphate.
    Siragy HM; Johns RA; Peach MJ; Carey RM
    Hypertension; 1992 Jun; 19(6 Pt 2):775-9. PubMed ID: 1317356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses.
    Tolins JP; Palmer RM; Moncada S; Raij L
    Am J Physiol; 1990 Mar; 258(3 Pt 2):H655-62. PubMed ID: 2156453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelium-derived relaxing factor in regulation of basal cardiopulmonary and renal function.
    Perrella MA; Hildebrand FL; Margulies KB; Burnett JC
    Am J Physiol; 1991 Aug; 261(2 Pt 2):R323-8. PubMed ID: 1877690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial cGMP does not regulate basal release of endothelium-derived relaxing factor in culture.
    Marczin N; Ryan US; Catravas JD
    Am J Physiol; 1992 Jul; 263(1 Pt 1):L113-21. PubMed ID: 1379001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor alpha activates soluble guanylate cyclase in bovine glomerular mesangial cells via an L-arginine-dependent mechanism.
    Marsden PA; Ballermann BJ
    J Exp Med; 1990 Dec; 172(6):1843-52. PubMed ID: 1979590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of endothelium-derived relaxing factor in the in vivo renal vascular action of adenosine in dogs.
    Okumura M; Miura K; Yamashita Y; Yukimura T; Yamamoto K
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1262-7. PubMed ID: 1545391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin system modulates renal bradykinin production.
    Siragy HM; Jaffa AA; Margolius HS; Carey RM
    Am J Physiol; 1996 Oct; 271(4 Pt 2):R1090-5. PubMed ID: 8898005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal hemodynamics in acute unilateral ureteral obstruction: contribution of endothelium-derived relaxing factor.
    Lanzone JA; Gulmi FA; Chou SY; Mooppan UM; Kim H
    J Urol; 1995 Jun; 153(6):2055-9. PubMed ID: 7752393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxygen modulates endothelium-derived relaxing factor production in fetal pulmonary arteries.
    Shaul PW; Farrar MA; Zellers TM
    Am J Physiol; 1992 Feb; 262(2 Pt 2):H355-64. PubMed ID: 1311528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of endothelium-derived relaxing factor in the pressure control of renin secretion from isolated perfused kidney.
    Scholz H; Kurtz A
    J Clin Invest; 1993 Mar; 91(3):1088-94. PubMed ID: 8383697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidences for the existence of endothelium-derived relaxing factor in the renal medulla.
    Biondi ML; Dousa T; Vanhoutte P; Romero JC
    Am J Hypertens; 1990 Nov; 3(11):876-8. PubMed ID: 2175626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The insulin-induced increase of guanosine-3',5'-cyclic monophosphate in human platelets is mediated by nitric oxide.
    Trovati M; Massucco P; Mattiello L; Piretto V; Cavalot F; Mularoni E; Anfossi G
    Diabetes; 1996 Jun; 45(6):768-70. PubMed ID: 8635651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
    Siragy HM; Carey RM
    J Clin Invest; 1997 Jul; 100(2):264-9. PubMed ID: 9218502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NG-monomethyl L-arginine inhibits endothelium-derived relaxing factor-stimulated cyclic GMP accumulation in cocultures of endothelial and vascular smooth muscle cells by an action specific to the endothelial cell.
    Johns RA; Peach MJ; Linden J; Tichotsky A
    Circ Res; 1990 Oct; 67(4):979-85. PubMed ID: 2170053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bradykinin B2 receptor modulates renal prostaglandin E2 and nitric oxide.
    Siragy HM; Jaffa AA; Margolius HS
    Hypertension; 1997 Mar; 29(3):757-62. PubMed ID: 9052892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of prostaglandins and endothelium-derived relaxing factor on the renal response to acetylcholine.
    Salom MG; Lahera V; Romero JC
    Am J Physiol; 1991 Jan; 260(1 Pt 2):F145-9. PubMed ID: 1992776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. Evidence for protein kinase C-mediated suppression of the cholinergic response.
    Craven PA; Studer RK; DeRubertis FR
    J Clin Invest; 1994 Jan; 93(1):311-20. PubMed ID: 7506712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N omega-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation.
    Ishii K; Chang B; Kerwin JF; Huang ZJ; Murad F
    Eur J Pharmacol; 1990 Feb; 176(2):219-23. PubMed ID: 2155799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of endothelial derived relaxing factor (EDRF) aggravates ischemic acute renal failure in anesthetized rats.
    Chintala MS; Chiu PJ; Vemulapalli S; Watkins RW; Sybertz EJ
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Sep; 348(3):305-10. PubMed ID: 8232607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.